The VPS13B Gene Cohen Syndrome Genetic Test is a specialized diagnostic examination designed to identify mutations in the VPS13B gene, which are responsible for causing Cohen Syndrome. This rare genetic disorder is characterized by developmental delay, intellectual disability, small head size (microcephaly), and distinctive facial features, among other symptoms. The test is a crucial tool for clinicians to accurately diagnose Cohen Syndrome, enabling appropriate management and support for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test employs advanced genetic sequencing technologies to scrutinize the VPS13B gene for any abnormalities that are indicative of Cohen Syndrome. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations.
The cost of the VPS13B Gene Cohen Syndrome Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the VPS13B gene. For families and individuals considering this test, it represents a significant step towards understanding and managing Cohen Syndrome, offering insights that can guide treatment decisions and support services.
The CNTN1 gene, associated with Compton-North Congenital Myopathy, plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a range of neuromuscular disorders, including Compton-North Congenital Myopathy, which is characterized by muscle weakness and developmental issues from birth. Recognizing the significance of early and accurate diagnosis for effective management and treatment, DNA Labs UAE offers a specialized genetic test targeting the CNTN1 gene.
The test is designed to identify mutations within the CNTN1 gene that could indicate the presence of Compton-North Congenital Myopathy, providing vital information for healthcare providers and affected families. This precise genetic analysis is crucial for confirming the diagnosis, understanding the condition's progression, and exploring potential treatment options tailored to the individual's genetic makeup.
Conducted in a state-of-the-art facility, the test is available for a cost of 4400 AED. DNA Labs UAE ensures that the process is handled with the utmost care and professionalism, delivering reliable and timely results. By opting for this genetic test, patients and their families can gain insights into the genetic underpinnings of Compton-North Congenital Myopathy, paving the way for a more informed approach to care and management.
The B3GALNT2 gene plays a critical role in the proper development and function of muscles and the brain, primarily due to its involvement in the glycosylation process of α-dystroglycan. Mutations in this gene can lead to a form of congenital muscular dystrophy, characterized by muscle weakness and brain abnormalities, along with a reduction in the glycosylation of α-dystroglycan - a key protein that connects the cytoskeleton of a muscle fiber to the surrounding extracellular matrix.
The genetic test for identifying mutations in the B3GALNT2 gene is crucial for diagnosing this specific subtype of congenital muscular dystrophy and its associated hypoglycosylation of α-dystroglycan. This test provides essential information for understanding the disease's progression, potential interventions, and management strategies for affected individuals.
Conducted at DNA Labs UAE, the test is priced at 4400 AED. DNA Labs UAE is known for its state-of-the-art facilities and expertise in genetic diagnostics, ensuring high accuracy and reliability of the test results. The test involves analyzing the patient's DNA to detect mutations in the B3GALNT2 gene that could lead to the disease, providing a critical tool for early diagnosis and the possibility of better clinical outcomes through timely and appropriate interventions.
The EGR2 Gene CMT4E Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the EGR2 gene, which are known to cause Charcot-Marie-Tooth disease type 4E (CMT4E), a rare and severe form of hereditary motor and sensory neuropathy. This condition is characterized by progressive muscle weakness and atrophy, sensory loss, and in some cases, severe neurological impairments. Early detection through genetic testing is crucial for the management and treatment of the disease, allowing for personalized care plans and genetic counseling for affected families.
DNA Labs UAE offers this comprehensive genetic test, employing advanced molecular techniques to accurately detect mutations in the EGR2 gene. The test is priced at 4400 AED, reflecting the intricate process of genetic analysis and the specialized expertise required to interpret the results. By choosing to undergo this test at DNA Labs UAE, patients and their families can expect high-quality service, detailed results, and professional guidance, aiding them in understanding their genetic health and making informed decisions about their care.
The MPZ Gene CMT4E Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MPZ gene, which are associated with Charcot-Marie-Tooth disease type 4E (CMT4E). CMT4E is a rare form of Charcot-Marie-Tooth disease, a neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory problems. The MPZ gene plays a crucial role in the functioning and structure of peripheral nerves, and mutations in this gene can disrupt nerve function, resulting in the symptoms of CMT4E.
This genetic test involves analyzing the patient's DNA to look for specific mutations in the MPZ gene that are known to cause CMT4E. It is a critical tool for confirming a diagnosis of CMT4E, enabling healthcare providers to tailor treatment plans and management strategies to the individual's condition. Furthermore, identifying the mutation can also provide valuable information for family planning and genetic counseling for affected families.
The MPZ Gene CMT4E Genetic Test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED. By offering this test, DNA Labs UAE aims to provide patients and their families with access to crucial information that can significantly impact the management of Charcot-Marie-Tooth disease type 4E, ultimately improving patient outcomes and quality of life.
The RAB7A Gene CMT2B Genetic Test is a specialized diagnostic tool designed to identify mutations in the RAB7A gene, which are associated with Charcot-Marie-Tooth disease type 2B (CMT2B). CMT2B is a rare form of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the feet and legs, sometimes affecting the hands and arms in the advanced stages of the disease.
This test is crucial for patients exhibiting symptoms of CMT2B or those with a family history of the condition, as it provides definitive genetic evidence of the RAB7A mutation. Early and accurate diagnosis through the RAB7A Gene CMT2B Genetic Test can significantly impact the management and treatment options for affected individuals, allowing for personalized care plans that can improve quality of life.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics, ensuring high standards of accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology used to identify the genetic mutation. By opting for this test at DNA Labs UAE, patients and their families can expect comprehensive support, from the initial consultation through to the interpretation of results and guidance on subsequent steps.
The LMNA Gene CMT2B1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the LMNA gene, which are associated with Charcot-Marie-Tooth disease type 2B1 (CMT2B1). This genetic condition is part of a group of disorders known as Charcot-Marie-Tooth (CMT) disease, characterized by peripheral neuropathy leading to muscle weakness and atrophy, primarily affecting the limbs. The LMNA gene plays a crucial role in encoding proteins essential for the structural integrity and function of the cell nucleus. Mutations in this gene can disrupt these processes, contributing to the development of CMT2B1.
The test is conducted using a blood sample, where DNA is extracted and analyzed for specific genetic alterations in the LMNA gene. It is a vital tool for individuals with a family history of CMT2B1, offering them crucial information regarding their genetic status and risk of developing the condition. Moreover, it aids in the early diagnosis and management of the disease, allowing for timely intervention and support.
The cost of the LMNA Gene CMT2B1 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to detect the presence of genetic mutations associated with CMT2B1, providing individuals and their families with essential insights into their genetic health and guiding future healthcare decisions.
The MED25 Gene CMT2B2 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the MED25 gene, which are associated with Charcot-Marie-Tooth disease type 2B2 (CMT2B2). CMT2B2 is a subtype of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the feet and legs, but also in the hands and arms as the condition progresses. The test is crucial for individuals with a family history of CMT2B2 or those showing symptoms, as it provides definitive genetic evidence of the condition. This information is vital for planning appropriate management and treatment strategies. The test cost is set at 4400 AED and is conducted with precision and care by the experienced professionals at DNA Labs UAE, ensuring reliable results for patients and their families.
The TRPV4 Gene CMT2C Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TRPV4 gene, which are associated with Charcot-Marie-Tooth disease type 2C (CMT2C). CMT2C is a rare form of Charcot-Marie-Tooth disease, a neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory loss primarily in the arms and legs. The TRPV4 gene plays a crucial role in the development and function of peripheral nerves, and mutations in this gene can disrupt nerve function, leading to the symptoms of CMT2C.
The test is conducted through a blood sample or a buccal swab, which is then analyzed to detect any genetic anomalies in the TRPV4 gene. This genetic test is pivotal for individuals who have a family history of CMT2C or exhibit symptoms related to peripheral neuropathies, as it can provide a definitive diagnosis of CMT2C. Early diagnosis through the TRPV4 Gene CMT2C Genetic Test can aid in the management and treatment of the condition, potentially improving the quality of life for affected individuals.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The test is performed with high accuracy and confidentiality, ensuring that patients receive reliable results along with the necessary support and information to understand their condition better.
The GARS1 Gene CMT2D Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the GARS1 gene that are associated with Charcot-Marie-Tooth disease type 2D (CMT2D). This condition is a type of inherited neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory problems primarily in the limbs. The test plays a crucial role in the early identification and management of CMT2D, enabling healthcare professionals to devise personalized treatment plans for affected individuals.
Performed using a sample of the patient's blood, the test specifically looks for genetic alterations in the GARS1 gene, which encodes an enzyme essential for the proper functioning of peripheral nerves. Identifying mutations in this gene can confirm a diagnosis of CMT2D, distinguish it from other forms of Charcot-Marie-Tooth disease, and help in understanding the inheritance pattern within families.
The cost of the GARS1 Gene CMT2D Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the sophisticated genetic analysis required to detect the relevant mutations, providing crucial information for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetics, ensuring accurate and reliable test results.
